BeyondSpring Inc. Segment Reporting Other Item Amount
BeyondSpring Inc. (BYSI) reported Segment Reporting Other Item Amount of $19.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Segment Reporting
us-gaap:SegmentReportingOtherItemAmount · last filed 2026-08-14
- BeyondSpring Inc. segment reporting other item amount for the quarter ending 2026-06-30 was $19.00K.
- BeyondSpring Inc. segment reporting other item amount for the quarter ending 2026-03-31 was $119.00K.
- BeyondSpring Inc. segment reporting other item amount for the quarter ending 2025-12-31 was -$86.00K, a 139.27% decline year-over-year.
- BeyondSpring Inc. segment reporting other item amount for the quarter ending 2025-09-30 was -$47.00K.
- BeyondSpring Inc. segment reporting other item amount for fiscal 2025 was -$230.00K, a 307.21% decline from fiscal 2024.
- BeyondSpring Inc. segment reporting other item amount for fiscal 2024 was $111.00K.
- BeyondSpring Inc. segment reporting other item amount for fiscal 2023 was -$1.07M.
| Period end | Segment Reporting Other Item Amount 3 month | Segment Reporting Other Item Amount 6 month | Segment Reporting Other Item Amount 9 month | Segment Reporting Other Item Amount 12 month |
|---|---|---|---|---|
| 2026-06-30 | $19.00K 10-Q · filed 2026-08-14 | $138.00K 10-Q · filed 2026-08-14 | $52.00K derived: sum of 3 quarters · filed 2026-08-14 | $5.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $119.00K 10-Q · filed 2026-05-13 | $33.00K derived: sum of 2 quarters · filed 2026-05-13 | -$14.00K derived: sum of 3 quarters · filed 2026-05-13 | -$85.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | -$86.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$133.00K derived: sum of 2 quarters · filed 2026-03-25 | -$204.00K derived: sum of 3 quarters · filed 2026-08-14 | -$230.00K 10-K · filed 2026-03-25 |
| 2025-09-30 | -$47.00K 10-Q · filed 2025-11-12 | -$118.00K derived: sum of 2 quarters · filed 2026-08-14 | -$144.00K 10-Q · filed 2025-11-12 | $75.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | -$71.00K 10-Q · filed 2026-08-14 | -$97.00K 10-Q · filed 2026-08-14 | $122.00K derived: sum of 3 quarters · filed 2026-08-14 | -$21.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | -$26.00K 10-Q · filed 2026-05-13 | $193.00K derived: sum of 2 quarters · filed 2026-05-13 | $50.00K derived: sum of 3 quarters · filed 2026-05-13 | $60.00K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $219.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $76.00K derived: sum of 2 quarters · filed 2026-03-25 | $86.00K derived: sum of 3 quarters · filed 2026-03-25 | $111.00K 10-K · filed 2026-03-25 |
| 2024-09-30 | -$143.00K 10-Q · filed 2025-11-12 | -$133.00K derived: sum of 2 quarters · filed 2025-11-12 | -$108.00K 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $10.00K 10-Q · filed 2025-08-13 | $35.00K 10-Q · filed 2025-08-13 | ||
| 2024-03-31 | $25.00K 10-Q · filed 2025-05-12 | |||
| 2023-12-31 | -$1.07M 10-K · filed 2025-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |